 |
Yahoo! News :: Health |
Heart experts clash on Vytorin and cancer risk (Reuters)Reuters - Experts clashed over the safety of Merck & Co and Schering-Plough's cholesterol drug Vytorin on Tuesday as full results from a controversial study were presented at Europe's biggest medical congress.View full item |
|
Go to syndication wizard for this feed Go to the history for this feed Go to the archive for this feed |
| Home | Syndication wizard | Contact us |
| Webhosting by VDX · Copyright © 2007-2008 FeedFan / Feed Folder |
| Other websites: CitySite · Favos · FeedFolder · FinPo · Starten |